Anti-GM-CSF Monoclonal Antibody Therapy for Refractory Acute Leukemia

References

• Metcalf D. The Haemopoietic Colony Stimulating Factors. Elsevier, Amsterdam, The Netherlands 1984
   Google Scholar
• Metcalf D. Haemopoietic growth factors now cloned. British Journal of Haematology 1986; 62: 409–411
   PubMed Web of Science ®Google Scholar
• Saeland S., Caux C., Favre C., Mannoni P., Pebusque M.J., Gentilhomme O., Otsuka T., Yokota T., Arai N., Arai K., Banchereau J., de Vries J.E. Effects of recombinant human Interleukin-3 on CD-34 enriched normal haematopoietic progenitors and on myeloblastic leukemia cells. Blood 1988; 72: 1580–1588
   PubMed Web of Science ®Google Scholar
• Sieff C.A., Emerson S.G., Donahue R.E., Nathan D.G. Human recombinant granulocyte-macrophage colony stimulating factor: A multilineage hematopoietin. Science 1985; 230: 1171–1173
   PubMed Web of Science ®Google Scholar
• Souza L.M., Boone T.C, Gabrilove J., Lai P.H., Zsebo K.M., Murdock D.C, Chazin V.R., Bruszewski J., Lu H., Chen K.K., Barendt J., Platzer E., Moore M.A.S., Mertelsmann R., Welte K. Recombinant human Granulocyte colony stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232: 61–65
   PubMed Web of Science ®Google Scholar
• Caracciolo D., Shirsat N., Wong G.G., Lange B, Clark S., Rovera G. Recombinant human Macrophage-Colony Stimulating Factor (M-CSF) requires subliminal concentrations of Granulocyte/Macrophage (GM)-CSF for optimal stimulation of human macrophage colony formation in vitro. Journal of Experimental Medicine 1987; 166: 1851–1860
   PubMed Web of Science ®Google Scholar
• Migliaccio G., Migliaccio A.R., Valinsky J., Langley K., Zsebo K., Visser J.W.M., Adamson J.W. Stem Cell Factor induces proliferation and differentiation of highly enriched murine hematopoietic cells. Proceedings of The National Academy of Science USA 1991; 88: 7420–7424
   PubMed Web of Science ®Google Scholar
• Mc Niece I.K., Langley K.E., Zsebo K.M. Recombinant human stem cell factor (rh-SCF) synergises with GM-CSF, G-CSF, 1L-3 and Epo to stimulate human progenitor cells of myeloid and erythroid lineages. Experimental Hematology 1991; 19: 226–231
   PubMed Web of Science ®Google Scholar
• Metcalf D. Hematopoietic regulators. Redundancy or subtlety?. Blood 1993; 82: 3515–3523
   PubMed Web of Science ®Google Scholar
• Sachs L. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: A model for the origin and progression of malignancy. Proceedings of The National Academy of Science USA 1980; 77: 6152–6156
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Regulation of cell surface receptor for different hematopoietic growth factors on myeloid leukemic cells. EMBO Journal 1986; 5: 2163–2170
   PubMed Web of Science ®Google Scholar
• Griffin J.D., Young D., Herrmann F., Wiper D., Wagner K., Sabbath K.D. Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 1986; 67: 1448–1453
   PubMed Web of Science ®Google Scholar
• Hoang T., Nara N., Wrong G., Clark S., Minden M.D., Mc Culloch E.A. Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia. Blood 1986; 68: 313–316
   PubMed Web of Science ®Google Scholar
• Kelleher C, Miyauchi J., Wong G., Clark S., Minden M.D., Mc Culloch E.A. Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia. Blood 1987; 69: 1498–1503
   PubMed Web of Science ®Google Scholar
• Sporn M.B., Roberts A.B. Autocrine, paracrine and endocrine mechanisms of growth control. Cancer Survey 1985; 4: 627–632
   PubMedGoogle Scholar
• Lang R.A., Metcalf D., Gough N.M., Dunn A.R., Gonda T.J. Expression of a hematopoietic growth factor cDNA in a factor-dependant cell line results in autonomous growth and tumorigenicity. Cell 1985; 43: 531–532
   PubMed Web of Science ®Google Scholar
• Young D.C., Griffin J.D. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1986; 68: 1178–1181
   PubMed Web of Science ®Google Scholar
• Sachs L. The control of growth and differentiation in normal and leukemic blood cells. Cancer 1990; 65: 2196–2206
   PubMed Web of Science ®Google Scholar
• Pebusque M.J., Lopez M., Torres H., Carotti A., Guilbert L., Mannoni P. Growth response of human myeloid leukemia cells to colony stimulating factors. Experimental Hematology 1988; 16: 360–366
   PubMed Web of Science ®Google Scholar
• Miyauchi J., Kelleher C.A., Yang Y.C, Wong G.G., Clark S.C, Minden M.D., Minkin S., Mc Culloch E.A. The effects of three recombinant growth factors, 1L-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood 1987; 70: 657–663
   PubMed Web of Science ®Google Scholar
• Young D.C, Wagner K., Griffin J.D. Constitutive expression of the Granulocyte-Macrophage Colony stimulating factor gene in acute myeloblastic leukemia. Journal of Clinical Investigation 1987; 79: 100–106
   PubMed Web of Science ®Google Scholar
• Young D.C, Demetri G.D., Ernst T.J., Cannistra S.A., Griffin J.D. In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells. Experimental Hematology 1988; 16: 378–382
   PubMed Web of Science ®Google Scholar
• Bradbury D., Rogers S., Reilly I.A.G., Kozlowski R., Russell N.H. Role of autocrine and paracrine production of Granulocyte-Macrophage Colony-stimulating factor and Interleukin-1β in the autonomous growth of acute myeloblastic leukemia cells-studies using purified CD34-positive cells. Leukemia 1992; 6: 562–566
   PubMed Web of Science ®Google Scholar
• Klein B., Wijdenes J., Zhang X.G., Jourdan M., Boiron J.M., Brochier J., Liautard J., Merlin M., Clement C, Morel-Fournier B., Lu Z.Y., Mannoni P., Sany J., Bataille R. Murine anti-Interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991; 78: 1198–1204
   PubMed Web of Science ®Google Scholar
• Waldmann T.A., Pastan I.H., Gansow O.A., Junghans R.P. The multichain Interleukin-2 Receptor: a target for immunotherapy. Annals of Internal Medicine 1992; 116: 148–160
   PubMed Web of Science ®Google Scholar
• Waldmann T.A., Goldman C.K., Bongiovanni K.F., Sharrow S.O., Davey M.P., Cease K.B., Greenberg S.J., Longo D.L. Therapy of patients with Human T-Cell Lymphotrophic Virus I-induced adult T-Cell Leukemia with Anti-Tac, a monoclonal antibody to the receptor for interleukin-2. Blood 1988; 72: 1805–1816
   PubMed Web of Science ®Google Scholar
• Nadler L.M., Stashenko P., Hardy R., Kaplan W.D., Button L.N., Kufe D.W., Antman K.H., Schlossman S.F. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Research 1980; 40: 3147–3154
   PubMed Web of Science ®Google Scholar
• Ritz J., Pesando J.M., Sallan S.E., Clawell L.A., Notis-Mc-Conarty J., Rosenthal P., Schlossman S.F. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 1981; 58: 141–152
   PubMed Web of Science ®Google Scholar
• Meeker T.C, Lowder J., Maloney D.G., Miller R.A., Thielemans K., Warnke R., Levy R. A clinical trial of Anti-Idiotype therapy for B cell malignancy. Blood 1985; 65: 1349–1363
   PubMed Web of Science ®Google Scholar
• Press O.W., Appelbaum F., Ledbetter J.A., Martin P.J., Zarling J., Kidd P., Thomas D. Monoclonal Antibody 1F5 (Anti-CD20) serotherapy of human B cell lymphoma. Blood 1987; 69: 584–591
   PubMed Web of Science ®Google Scholar
• Brown S.L., Miller R.A., Horning S.J., Czerwinski D., Hart S.M., McElderry R., Basham T., Warnke R.A., Merigan T.C., Levy R. Treatment of B-Cell lymphomas with Anti-Idiotype Antibodies alone and in combination with Alpha Interferon. Blood 1989; 73: 651–661
   PubMed Web of Science ®Google Scholar
• Ball E.D., Bernier G.M., Cornwell G.G., Ill, Ross McIntyre O., O'Donnell J.F., Fanger M.W. Monoclonal Antibodies to myeloid differentiation antigens: In vivo studies of three patients with acute myelogenous leukemia. Blood 1983; 62: 1203–1210
   PubMed Web of Science ®Google Scholar
• Scheinberg D.A., Lovett D., Divgi C.R., Graham M.C, Berman E., Pentlow K., Feirt N., Finn R.D., Clarkson B.D., Gee T.S., Larson S.M., Oettgen H.F., Old L.J. A phase I trial of monoclonal Antibody M195 in acute myelogenous leukemia: Specific bone marrow targeting and internalization of radionuclide. Journal of Clinical Oncology 1991; 9: 478–490
   PubMed Web of Science ®Google Scholar